Concepedia

Robert M. DiPardo

RM

Statistics

Publications

45

Citations

3.5K

H-Index

25

Active since

1975

Affiliations

United States Military Academy(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Robert M. DiPardo is an author at United States Military Academy specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1975–2011

45

Publications

45

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

B. Evans, Kenneth E. Rittle, Mark G. Bock et al. · Journal of Medicinal Chemistry · 1988 · 1.4K citations · Full text

, , +13

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin.

B. Evans, Mark G. Bock, Kenneth E. Rittle et al. · Proceedings of the National Academy of Sciences · 1986 · 328 citations · Full text

, , +16

Benzodiazepine gastrin and brain cholecystokinin receptor ligands; L-365,260

Mark G. Bock, Robert M. DiPardo, B. Evans et al. · Journal of Medicinal Chemistry · 1989 · 310 citations · Full text

, , +8

Tetrabutylammonium Salt Induced Denitration of Nitropyridines:  Synthesis of Fluoro-, Hydroxy-, and Methoxypyridines

Scott D. Kuduk, Robert M. DiPardo, Mark G. Bock · Organic Letters · 2005 · 87 citations

, , +6

Discovery of a Potent, Non-peptide Bradykinin B<sub>1</sub> Receptor Antagonist

Dai‐Shi Su, M. Kristine Markowitz, Robert M. DiPardo et al. · Journal of the American Chemical Society · 2003 · 81 citations

, , +17

1–5 of 45